RENAL-ALLOGRAFT SURVIVAL ACCORDING TO PRIMARY DIAGNOSIS - A REPORT OFTHE NORTH-AMERICAN PEDIATRIC RENAL-TRANSPLANT COOPERATIVE STUDY

Citation
Ce. Kashtan et al., RENAL-ALLOGRAFT SURVIVAL ACCORDING TO PRIMARY DIAGNOSIS - A REPORT OFTHE NORTH-AMERICAN PEDIATRIC RENAL-TRANSPLANT COOPERATIVE STUDY, Pediatric nephrology, 9(6), 1995, pp. 679-684
Citations number
22
Categorie Soggetti
Pediatrics,"Urology & Nephrology
Journal title
Pediatric nephrology
ISSN journal
0931041X → ACNP
Volume
9
Issue
6
Year of publication
1995
Pages
679 - 684
Database
ISI
SICI code
0931-041X(1995)9:6<679:RSATPD>2.0.ZU;2-D
Abstract
The data base of the North American Pediatric Renal Transplant Coopera tive Study (NAPRTCS) was used to examine the effect of primary diagnos is on the outcome of renal transplantation in children. The relative r isk of graft failure for eight diagnostic groups was determined, with patients with congenital and structural anomalies of the urinary tract serving as the reference group. Covariate analysis was used to contro l for the effects of age, race and transfusion history in recipients o f living-related donor kidneys, and for age, donor age, antilymphocyte prophylaxis, prior transplantation, prior dialysis and cold ischemia time in recipients of cadaver kidneys. In recipients of living-related donor kidneys, the lowest graft failure rates were associated with th e diagnoses of cystinosis, familial nephritis and hemolytic uremic syn drome (HUS), while the highest failure rates were observed in patients with a primary diagnosis of congenital nephrotic syndrome (CNS) or fo cal segmental glomerulosclerosis (FSGS). In cadaver allograft recipien ts, the lowest graft failure rates were associated with primary diagno ses of glomerulonephritis, congenital/structural disease and cystinosi s, while patients with FSGS, HUS and CNS had the highest graft failure rates, This study suggests that patients with a primary diagnosis of cystinosis have superior outcomes, while the diagnoses of FSGS and CNS carry with them the highest risks of graft failure.